We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.
First quarter results 2025
Investors event calendar
View recent presentations and learn more about upcoming events.
May 13-14, 2025
Bank of America Healthcare Conference
Las Vegas, USA
Environmental, Social and Governance (ESG)
Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.
ESG updates: May 2025 (PDF 0.9 MB) | February 2025 (PDF 1.0 MB) | October 2024 (PDF 0.6 MB) | July 2024 (PDF 0.9 MB)
Latest updates: Impact & Sustainability (PDF 1.9 MB) | Impact & Health Equity (PDF 9.9 MB) | Novartis Enterprise Risk Management (PDF 0.2 MB)
We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.
Reporting and transparency hub
Read our regulatory filings; policies, codes and guidelines that govern our activities; and environmental, social and governance (ESG) disclosures.
Stocks
Media releases
Novartis to acquire Regulus Therapeutics and farabursen, an investigational microRNA inhibitor to treat ADPKD, the most common genetic cause of renal failure
Novartis continues strong momentum with double-digit sales growth, robust margin expansion and multiple approvals in Q1
Novartis receives FDA accelerated approval for Vanrafia® (atrasentan), the first and only selective endothelin A receptor antagonist for proteinuria reduction in primary IgA nephropathy (IgAN)
Pulse updates, Novartis implements manufacturing adjustments for ribociclib to ensure alignment with latest regulatory standards in eB
Other Areas - Partnering tab
Seeking transformative approaches to address genetic disease
Elizabeth Leshen
Ophthalmology
Seeking to develop and deliver life-changing medicines for diseases and conditions from front to back of the eye, enabled by data, transformative technologies, and partnerships.
Andreas Sailer
Renal
Interested in disease modifying treatments and renal indications with high unmet need.
Andreas Sailer
We accept that innovation happens outside of areas of interest- we are still prepared to discuss transformational areas we may have missed. We have a special team for you to talk with.
Andreas Sailer
Pulse updates, Novartis implements manufacturing adjustments for ribociclib to ensure alignment with latest regulatory standards in eB
Pulse updates, Novartis implements manufacturing adjustments for ribociclib to ensure alignment with latest regulatory standards in eB
Types of migraine
Migraine manifests in different ways, but a person experiencing a migraine can go through four distinct phases. The main headache phase of migraine typically lasts from 4 to 72 hours. Prior to this, some individuals can experience pre-migraine warning signs, including fatigue and sleep disorders, hours or even days before the attack. This is known as the ‘prodromal phase’. Some people also experience aura - visual, sensory and speech disturbances. Individuals may also experience lingering effects of migraine following an attack. Symptoms include altered mood, nausea and fatigue. This is known as the ‘postdromal phase’.
Based on the frequency of the headaches experienced in a month, a migraine can be characterized as episodic or chronic – episodic migraine (EM) is characterized by 0 to 14 headache days per month, while chronic migraine (CM) is characterized by 15 or more headache days per month. There are several types of migraine based on the different symptoms and triggers that people living with migraine can experience. Some of the examples are:
| Type of Migraine | Characterization |
|---|---|
| Migraine without aura | One of the most common types, experienced by 70-90% of people living with migraine. The headache is usually on one side of the head with a throbbing or pulsating pain. Other symptoms include nausea, diarrhea, photophobia and phonophobia. |
| Migraine with aura | In addition to the symptoms mentioned above, people who experience migraine with aura also experience visual disturbances. |
| Menstrual migraine | This type of migraine is triggered by menstruation and is experienced by approximately 10% of women. |
| Hemiplegic migraine | This is a rare type of migraine, which in addition to the usual symptoms also causes temporary weakness, numbness and tingling, and paralysis on one side of the body. |
| Vestibular migraine | During this type of migraine attack, people experience vertigo dizziness or balance problems in addition to the usual migraine symptoms. |
| Exercise migraine | This type of migraine is triggered by exercising and physical activity and is experienced by 20-40% of people living with migraine. |
The symptoms and triggers of migraine can greatly differ from person to person, making it difficult to diagnose and manage.